Picture
Health and medical research sits at the core of Australia's R&D system. There are roughly 200 biotech and healthcare companies listed on the ASX. There are more than 120 Australian universities, hospitals, and medical research institutes active in health and medical research. In total, $8 billion is spent annually on health and medical R&D in Australia.

The Australian Medical Precincts Report  looks at the impact of this investment on 30 health and medical research precincts around Australia. It takes a data-centric approach to:
  • analyse the research output of 120 organisations and their 30 precincts across 21 key disease areas;
  • contrast the distribution of ASX-listed healthcare companies with the activities of public and non-profit institutions; and
  • provide strategic analysis of organisational competitive advantage and pinpoint 5 critical factors for precinct success.
​
An organisation's success in health and medical research is heavily influenced by its environment - especially its proximity to other research organisations. The Australian Medical Precincts Report helps organisations understand how to compete and differentiate in a highly competitive system.

Australia has spent $100 billion on health and medical research over the past 20 years ...

​... what have we got for it?